Korean pharmas busy recruiting talent from global pharmas
By Lee, Seok-Jun | translator Kim, Jung-Ju
23.07.20 05:50:42
가나다라
0
Handok appoints former Pfizer personnel Miyeon Kim as new CEO, Yoon-Mi Kim as Executive Director
Hana Pharm appoints former Janssen employee Tae-Hong Choi as President/CEO to accelerate its global business
Anterogen, Shaperon, Lotte Biologics also appoints personnel well-versed in global affairs
Korea's pharmaceutical and bio businesses are busy recruiting talents from multinational pharmaceutical companies to further accelerate their global entry.
Handok appointed Miyeon Kim (56) as the new CEO as of July 1st.
At Pfizer, the new CEO Kim worked as the Strategic Planning Manager, Product Manager, Marketing Manager, and as the BU Lead of the company’s Established Products Business Unit. Afterward, she was appointed VP of Pfizer’s Established Products Business Unit at Pfizer US and led the US Brands Team. Kim also has served as the Cardiovascular Metabolic Franchise Head and Country General Manager of Alcon.
In June, Handok had appointed Yoon-Mi Kim as Exec
Lee, Seok-Jun(wiviwivi@dailypharm.com)
If you want to see the full article, please JOIN US (click)